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Introduction
The World Health Organisation’s (WHO) integrated strategy 
for blood safety has 4 key components one of  which is 
collecting blood only from voluntary non-remunerated 
blood donors (VNRBDs) from low risk population groups1. 
Identifying low risk population groups involves analysing 
general population and blood donor specific data to identify 
possible risk factors for transfusion transmissible infections 
(TTIs). When establishing the national blood donation 
criteria at the start of  its operations in 2004, the Malawi 
Blood Transfusion Service (MBTS) relied on international 
recommendations and local general population based data1-
2. There was no national data on any type of  blood donors. 
The available published TTI prevalence reports on blood 
donors in Malawi were only for family replacement blood 
donors.4-7, 8-10 These reports were either based on incomplete 
program data4-7 or old studies dating back 12-18 years8-10 
with no recent seroprevalence reports for voluntary non-
remunerated blood donors. 
The WHO recommendation to collect blood only from 
voluntary non-remunerated blood donors was based on 
their lower prevalence of  TTIs when compared with 
family replacement blood donors and paid blood donors11. 
Voluntary non-remunerated blood donors are a self-selected 
sub-population that is different to the general population. 
To improve the safety of  the national blood supply, it is also 
important to analyse blood donor specific data in this sub-
population in order to identify patterns that are specific to 
this population12-13. This study, therefore, provides, for the 
first time in Malawi, information on the prevalence and trend 
of  prevalence of  transfusion transmissible infections (TTIs) 
and socio-demographic factors associated with positivity for 
TTIs among voluntary non-remunerated blood donors. 
Methods
Study design, setting and study subjects
A retrospective descriptive study of  blood donor data 
recorded in the electronic database at the Malawi Blood 
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Transfusion Service (MBTS) in Blantyre was performed in 
2016. This database contains information routinely collected 
from all blood donors who donate blood at the MBTS 
from 27 of  the 28 districts in Malawi. The MBTS does not 
collect blood from Likoma district for logistical reasons as 
this district is only reachable by unreliable water transport. 
The study population was voluntary non-remunerated blood 
donors (VNRBDs) who donated blood at the MBTS in the 
5 year period from January 2011 to December 2015. The 
MBTS implements two levels of  screening of  blood donors: 
pre-donation and post-donation screening. Pre-donation 
screening also has two stages which are: educating blood 
donors on the eligibility criteria for blood donation which 
aims at encouraging self-deferral among potential blood 
donors and administering a blood donation questionnaire 
which contains the national blood donation acceptability 
criteria. This helps screen out those who are not eligible to 
donate blood. The exclusion criteria for blood donation is 
extensive. It includes, among others, those who are unwell 
or feel unhealthy; those who engage in behaviour deemed at 
risk for transfusion transmissible infections (TTIs) such as 
tattooing and multiple sexual partners; age below 16 or above 
65 years; past medical history suggestive of  HIV, hepatitis 
or syphilis; past or present history of  renal, cardiovascular, 
central nervous system and metabolic disorders such as 
insulin dependent diabetes; haemoglobin below 12.5g/dl 
and weight below 42 kgs. Only individuals who satisfy the 
national blood donation acceptability criteria are accepted 
as blood donors and hence are allowed to donate blood. 
Records of  these individuals are kept in the electronic MBTS 
database. The second phase of  screening involves post-
donation laboratory testing of  the donated blood for HIV, 
hepatitis B virus (HBV), hepatitis C virus (HCV), syphilis 
and malaria parasites. 
Sample size 
Using the Taro Yamane method for sample size calculation 
for a finite population [formula:,  a 95% confidence interval, 
a type one error of  5%, and an estimated population of  
150,000 blood donors, the sample size was estimated to 
be 399. However, all blood donors in the MBTS data base 
during the study period of  January 2011 to December 2015 
were included in the study. This approach was taken because 
the MBTS stores blood donor information in an electronic 
database that could easily be retrieved without taking too 
much time. Because of  this approach, the study population 
for each of  the 5 years from 2011 to 2015 ranged from 
37,111 to 41,728. 
Data collection and management
The following information was retrieved from the MBTS 
database and extracted into an Excel database: blood 
donor serology test results, age, sex, marital status, place of  
donation, occupation and number of  donations. The various 
entries for occupation in the database were grouped into 4 
categories that were used for analysis as follows: student, 
business/self-employed, employed (for those in formal 
employment) and ‘others’ to include the unemployed and all 
other occupation categories that did not easily fit into the 
first 3 categories. Places of  donation were also organized 
from the individual names of  villages, schools, workplaces 
and places of  worship to districts thereby ending up with 
27 places of  donation. These 27 places were then grouped 
into 3 regions of  Northern, Central and Southern regions of  
Malawi. Marital status was categorised into single, married, 
divorced/separated and widowed. 
In line with the global pledge 25 blood donor retention 
strategy and the 16-25 year age-group of  enrolment into the 
Malawi Club 25, age was also analysed as a binary variable 
as follows: those aged ≤25 years and >25 years14. Number 
of  blood donations was also dichotomized to first time 
blood donors being those with 1 or less blood donations and 
repeat blood donors being those with more than 1 blood 
donation. The blood donor test results were limited to those 
for HIV, HBV, HCV and syphilis. The MBTS participates in 
an external quality assessment (EQA) program for all these 
tests. It does not participate in an EQA program for malaria 
parasite testing. This is why blood donor test results for 
malaria parasite testing were left out of  this study. 
Laboratory screening
For the blood test results, all tests were performed according 
to the manufacturer’s instructions and validated standard 
operating procedures. The assays and algorithms used to 
determine a positive result were as follows:
HIV serology
Green screen ULTRA HIV antigen-antibody reagents 
(Bio-Rad, France) were utilised using the Evolis semi-
automated platform. These were fourth generation enzyme 
immunoassays (EIA) that detect antibodies to HIV-I (groups 
M and O) and HIV-II as well as the HIV p24 antigen. The 
algorithm involved repeating in duplicate all initial positives 
and interpreting results based on concordant two of  the 
three. From August 2015, supplementary testing with 
Determine antibody rapid test kits (Allere, Japan) was added 
for those found positive with the EIA algorithm. Before 
2015, in the database there were just two results categories: 
positive and negative. However, since 2015 a third category 
of  discordant was added being those who test positive on 
EIA and negative on rapid test kit. 
HBV serology
Monalisa HBsAg ULTRA reagents, (Bio-Rad, France) on 
the Evolis semi-automated platform were used.  These 
were fourth generation EIA reagents that detect the HBV 
surface antigen (HBsAg). The algorithm involved repeating 
in duplicate all initial positives and interpreting results based 
on concordant two of  the three.
HCV serology
Monalisa anti-HCV PLUS version3 reagents, (Bio-Rad, 
France) on the Evolis semi-automated platform were used. 
These were third generation EIA reagents which detect 
antibodies to the NS3 and NS4 regions of  the capsid of  
the hepatitis C virus. The algorithm involved repeating in 
duplicate all initial positives and interpreting results based on 
concordant two of  the three.
Syphilis serology
Manual Treponema Pallidum Haemaglutination Assay 
(TPHA) reagents (Bio-Rad, France) using micro plates were 
used. These detect IgG antibodies to Treponema pallidum. The 
algorithm involved repeating in duplicate all initial positives 
and interpreting results based on concordant two of  the 
three.
Statistical analysis
Data was cleaned, recoded and analyzed using Stata for 
Windows version 12.  Summary statistics from the number 
of  individual blood donors in the MBTS database per year 
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the blood donors(72.1%) were students, 14.4% employed, 
6.4% self-employed, 6.5% were in the other employment 
category. The proportion of  first time blood donors was 
44.0% with 56.0% being repeat blood donors.  
Annual prevalence of TTIs in blood donors
In 2015, the overall positivity rates of  HBV, syphilis, HIV 
and HCV were 3.6%, 2.6%, 1.9%, and 1.0 %, respectively 
(Table 1).  Prevalence of  each TTI was higher in first time 
blood donors compared to repeat blood donors. The annual 
prevalence of  each infection in all blood donors was lower in 
the northern region when compared with the other 2 regions 
(Table 1).
Trend of prevalence of TTIs in all blood donors
The most prevalent TTI over this 5 year period was hepatitis 
B while hepatitis C had the lowest prevalence (Figure 1).
Across the 5 year period, HIV prevalence was higher than 
syphilis from 2011 to 2013 afterwards  syphilis prevalence 
for each of  this 5 year period were calculated.  Annual 
prevalence was calculated and expressed in percentages per 
year for each infection for all blood donors and separately 
for first time blood donors and for repeat blood donors. 
These were used to plot graphs to illustrate the 5 year trend 
of  annual prevalence. The Cochran-Armitage Test for trend 
of  proportions was used to test the statistical significance of  
the observed trends. 
To determine the relationship between a positive TTI result 
with age, sex, marital status, occupation and number of  
donations,  univariable and multivariable logistic regression 
analyses were performed  using the latest (2015) group of  
blood donors.  to evaluate the relationship.. Although all 
blood donors who donated blood in 2015  were used in the 
analysis, they were still a sample of  all blood donors.  As 
such 95% confidence intervals (CI) were calculated for the 
odds ratios (OR) and the adjusted odds ratios (AOR). For all 
statistical tests, the level of  significance was evaluated at 0.05.
Missing data
One of  the main challenges with using secondary data is 
that some needed data maybe missing and some data may 
be incorrectly captured into the database.  For this study, 
missing data for summary statistics was below 2% for all 
parameters and missing data for calculating prevalence 
ranged from 2.3% in 2011 to 17.5% in 2015. Missing data 
mainly constituted those blood donors whose blood test 
results were absent from the database for that particular 
year. This was caused by failure of  laboratory personnel to 
manually enter into the database all blood test results. The 
missing data was random and non-differential and did not 
each exceed 20%. As such missing data did not affect the 
results of  this study.
Ethical considerations
To ensure donor confidentiality, data was anonymised with 
all personal identifiers removed. 
New numbers were allocated to the study participants that 
could not be linked to the blood donors.  The process of  
delinking donor identities was undertaken exclusively by 
a data manager from Malawi Blood Transfusion Service 
(MBTS). All records were kept in a secure area. 
Only secondary data which had been generated using 
procedures pre-consented to by the blood donors themselves 
was used hence no fresh consent was sought from the blood 
donors. Permission to carry out the research was granted 
by the MBTS and ethical approval was obtained from the 
College of  Medicine Research and Ethics Committee 
(COMREC). 
Results
Socio-demographic characteristics of the study 
population
A total of  125,893 different individuals donated blood to 
the MBTS over the period from January 2011 to December 
2015. Some of  them donated blood more than once in 
each year. On average 39, 289 people donated blood to 
the MBTS per year of  whom 44.7% donated blood in the 
southern region; 38.3% in the central region and 17.0% 
in the northern region.  The blood donors were generally 
young with median age of  19 years (interquartile range 17-24 
years), 79.8% of  the blood donors were aged 25 years and 
below; 82.0% were male, 18.0% female; 87% were single, 
12% married, 0.3% divorced and 0.1% widowed. Most of  
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1.9 1.7-2.1 3.8 3.5-4.1 1.1 1.0-1.3 2.6 2.4-2.9
Table 1 Prevalence of infections in blood donors in 2015
Figure 1 Trend of prevalence of transfusion transmissible infections 
in all blood donors 
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became higher. Overall, the general trend was that prevalence 
of  infections went down between 2011 and 2015. This 
finding was statistically significant with a p-value of  <0.001 
for each infection (Cochran-Armitage Test for trend of  
proportions). The 2015 prevalence was: 3.6% (1,239/34,437) 
for HBV; 1.9% (655/34,437) for HIV; 2.6% (896/34,437) 
for Syphilis and 1.0% (343/34,437) for HCV while the 
2011 prevalence was 4.7% (1,744/36,961) for HBV; 3.5% 
(1,283/36,961); for HIV 3.2% (1,200/36,961) for Syphilis 
and 2.4% (904/36,961) for HCV.  
Trend of prevalence of TTIs in first time blood 
donors
The trend of  prevalence of  TTIs in first time blood donors 
was similar to that in all blood donors (Figure 1 and Figure 
2) and was statistically significant with a p-value, <0.001 
for each infection. For this group, HIV fell from 5.3% 
(837/15,709) in 2011 to 2.8% (432/15,560) in 2015; HBV 
fell from 7.4% 1,163/15,709) in 2011 to 5.1 (795/15,560) 
%  in 2015; syphilis fell from 4.7% (746/15,709) to 3.3% 
(514/15,560)  and HCV fell from 2.9 (452/15,709) to 1.2% 
(183/15,560). 
Trend of prevalence of TTIs in repeat blood donors
Figure 3 shows that over the 5 year period, hepatitis B had 
the highest prevalence in repeat blood donors and hepatitis C 
had the lowest prevalence with HIV and syphilis in between. 
HIV prevalence was higher than syphilis from 2011 to 
2013 after which syphilis prevalence became higher. The 
general trend is that prevalence of  infections in repeat blood 
donors fell for all infections except syphilis: for HIV it fell 
from 2.1% (451/21,252) in 2011 to 1.2% (225/18,877) in 
2015; HBV fell from 2.7% (574/21,252)   in 2011 to 2.3% 
(427/18,877)   in 2015; HCV fell from 2.1% (436/21,252) to 
0.9% (173/18,877). Syphilis fell from 2.2% (459/21,252)   in 
2011 to 1.6% in 2013 and 14 but rose to 2.1% (390/18,877) 
in 2015. For all infections there was a rise in prevalence from 
2014 to 2015 with relatively more marked rises for syphilis and 
HBV. The Cochran-Armitage Test for trend of  proportions 
shows that the 5 year downward trend of  proportions for 
HIV, HBV and HCV, was statistically significant (p-value, 
<0.001 for each infection) while that for syphilis was not 
statistically significant (p-value, 0.19).
Factors associated with HIV, hepatitis B, hepatitis 
C and Syphilis
An HIV positive result was significantly associated with age 
above 25 years, first time blood donors and being out of  
school (Table 2); hepatitis B was significantly associated with 
males and first time blood donors (Table 3); hepatitis C was 
significantly associated with age below 25 years, male sex and 
first time blood donors (Table 4) while factors significantly 
associated with a positive syphilis result were: being male, 
Figure 2 Trend of prevalence of transfusion transmissible infections 
in first time blood donors
Figure 3 Trend of prevalence of transfusion transmissible infections 
in repeat blood donors
Variable Prevalence (%)
OR
Univariable analysis Multivariable analysis
95% CI p-value AOR 95% CI p-value
Age 
(n=34,380)
≤25 years (n=27,337) 1.5 Reference
>25years (n=7,043) 3.7 1.98 1.73-2.28 <0.001 1.46 1.17-1.83 0.001
Sex 
(n=34,380)
Male (n=27,533) 2.0 Reference
Female (n=6847) 1.9 0.93 0.78-1.10 0.376 Not done
Marital Status
(n=34,322)
Single (n=29,740) 1.7 Reference
Married (n=4,443) 3.7 1.94 1.65-2.27 <0.001 0.98 0.79-1.22 0.847
Divorced (n=109) 2.8 1.55 0.57-4.21 0.392 0.80 0.29-2.21 0.666
Widow/er (n=30) 6.7 2.90 0.69-12.21 0.146 1.35 0.32-5.76 0.682
Occupation
(n=34,311)
Student (n=25,400) 1.4 Reference
Employed (n=4,231) 3.0 1.74 1.46-2.09 <0.001 1.35 1.04-1.73 0.022
Self-Employed (n=2,102) 4.6 2.52 2.05-3.11 <0.001 1.85 1.42-2.40 <0.001
Other (n=2,578) 3.3 1.98 1.60-2.44 <0.001 1.35 1.04-1.76 0.026
 Donation times
(n=34,380)
≤1 (n=15,526) 2.8 Reference
>1 (n=18,854) 1.2 0.48 0.42-0.55 <0.001 0.48 0.42-0.55 <0.001
Table 2: Factors associated with HIV
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Table 3: Factors associated with hepatitis B
Variable Prevalence (%)
OR
Univariable analysis Multivariable analysis
95% CI p-value AOR 95% CI p-value
Age 
(n=34,380)
≤25 years (n=27,337) 3.5 Reference
>25years (n=7,043) 3.9 1.14 0.99-1.30 0.063 Not done
Sex 
(n=34,380)
Male (n=27,533) 3.9 Reference
Female (n=6847) 2.2 0.56 0.47-0.66 <0.001 0.51 0.43-0.60 <0.001
Marital Status
(n=34,322)
Single (n=29,740) 3.4 Reference
Married (n=4,443) 4.4 1.29 1.11-1.51 0.001 1.14 0.92-1.41 0.217
Divorced (n=109) 4.6 1.35 0.55-3.32 0.511 1.30 0.52-3.23 0.579
Widow/er (n=30) 0.1 3.12 0.95-10.32 0,062 3.21 0.95-10.85 0.060
Occupation
(n=34,311)
Student (n=25,400) 3.5 Reference
Employed (n=4,231) 3.2 0.93 0.77-1.11 0.414 0.81 0.65-1.01 0.064
Self-Employed (n=2,102) 4.6 1.35 1.09-1.67 0.006 1.10 0.86-1.40 0.432
Other (n=2,578) 4.5 1.33 1.09-1.62 0.005 0.98 0.78-1.24 0.880
 Donation times
(n=34,380)
≤1 (n=15,526) 5.1 Reference
>1 (n=18,854) 2.3 0.44 0.39-0.49 <0.001 0.43 0.38-0.48 <0.001
Table 4 Factors associated with hepatitis C
Variable Prevalence (%)
OR
Univariable analysis Multivariable analysis
95% CI p-value AOR 95% CI p-value
Age 
(n=34,380)
≤25 years (n=27,337) 1.2 Reference
>25years (n=7,043) 0.5 0.47 0.33-0.66 <0.001 0.47 0.30-0.74 0.001
Sex  (n=34,380) Male (n=27,533) 1.1 Reference
Female (n=6847) 0.7 0.65 0.48-0.88 0.006 0.59 0.44-0.80 0.001
Marital Status
(n=34,322)
Single (n=29,740) 1.1 Reference
Married (n=4,443) 0.8 0.77 0.54-1.08 0.130
Not doneDivorced (n=109) 0 1 - -
Widow/er (n=30) 0 1 - -
Occupation
(n=34,311)
Student (n=25,400) 1.1 Reference
Employed (n=4,231) 0.7 0.61 0.41-0.89 0.011 0.96 0.60-1.53 0.859
Self-Employed (n=2,102) 0.7 0.59 0.34-1.01 0.055 0.83 0.46-1.48 0.518
Other (n=2,578) 0.9 0.76 0.49-1.17 0.212 0.99 0.62-1.58 0.959
 Donation times
(n=34,380)
≤1 (n=15,526) 1.2 Reference
>1 (n=18,854) 0.9 0.78 0.63-0.96 <0.019 0.75 0.60-0.92 0.007
Variable Prevalence (%)
OR
Univariable analysis Multivariable analysis
95% CI p-value AOR 95% CI p-value
Age 
(n=34,380)
≤25 years (n=27,337) 2.5 Reference
>25years (n=7,043) 3.4 1.37 1.18-1.60 <0.001 1.04 0.82-1.33 0.726
Sex  (n=34,380) Male (n=27,533) 2.9 Reference
Female (n=6847) 1.8 0.62 0.51-0.75 <0.001 0.61 0.50-0.74 <0.001
Marital Status
(n=34,322)
Single (n=29,740) 2.4 Reference
Married (n=4,443) 4.2 1.76 1.49-2.07 <0.001 1.54 1.21-1.97 0.001
Divorced (n=109) 3.7 1.53 0.56-4.17 0.403 1.41 0.51-3.90 0.509
Widow/er (n=30) 0 1 - - - - -
Occupation
(n=34,311)
Student (n=25,400) 2.4 Reference
Employed (n=4,231) 2.5 1.04 0.84-1.28 0.716 0.76 0.57-1.01 0.058
Self-Employed (n=2,102) 4.7 2.02 1.63-2.51 <0.001 1.44 1.09-1.90 0.011
Other (n=2,578) 3.6 1.51 1.21-1.89 <0.001 1.02 0.77-1.35 0.891
 Donation times
(n=34,380)
≤1 (n=15,526) 3.3 Reference
>1 (n=18,854) 2.1 0.62 0.54-0.71 <0.001 0.63 0.55-0.72 <0.001
Table 5 Factors associated with syphilis 
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first time blood donor, married and self-employed (Table 5). 
Discussions
Typical blood donor in Malawi
The results of  this study show that a typical voluntary non-
remunerated blood donor (VNRBD) in Malawi is young, 
single, male and a student. The dominance of  young 
unmarried males in the blood donor population is likely self-
selection based on the population risk of  HIV and explains 
the generally lower rate of  prevalence in our study population 
compared to the national rates of  10.6% in 2010 and 10.4% 
in 201515. At population level, HIV transmission in Malawi is 
mainly through stable heterosexual relationships. Prevalence 
is higher in those who have ever been married with rates 
of  3% for never been married, 9.8% for those currently 
married, 19.1% for those who are divorced or separated and 
32.3% for those widowed15-16. At HIV prevalence of  6.4% 
for males aged 15-54 years compared with 10.8% for females 
aged 15-49 years, males in Malawi have a lower prevalence of  
HIV than females15. This population level gender disparity 
in HIV prevalence is even more marked at a younger age: 
1% for males against 4.9% for females aged 15-24 years15. 
However, in our study population, gender and marital status 
were not associated with a positive HIV result. This is 
probably because our study population was heavily skewed 
towards unmarried males. On the other hand, age above 25 
years was associated with a higher HIV prevalence, a trend 
also observed in the general population15.
Prevalence of transfusion transmissible infections 
During the period under study the prevalence of  all transfusion 
transmissible infections (TTIs) showed a downward trend. 
The test kits and testing algorithm remained the same for 
all TTIs except for HIV whereby a supplementary rapid test 
kit had been added for all initial positives from August 2015. 
This additional test meant that some of  the initial positive 
reactions were found non-reactive and were thus labeled 
as discordant and classified as part of  the missing data. 
However, discordant results for HIV in 2015 were only 0.6% 
with missing data for all years ranging from 2.3% for 2011 
to 17.5% for 2015 blood donors. This missing data was non-
differential and was also less than 20% for each year’s data. In 
view of  the short time from August to December 2015 when 
the HIV test algorithm was modified and the low level of  
missing data, it is suggestive that the general downward trend 
observed over this period is most likely a real observation. 
Additionally, the repeat blood donation rates over this period 
declined from 57.5% in 2011 to 51.0% in 2015 and the 
pattern of  decline in TTI prevalence for all blood donors 
was similar to the pattern of  decline in first time blood 
donors suggesting that this decline in prevalence was due to 
other factors and not an increase in the proportion of  repeat 
blood donors or changes in laboratory screening methods. 
While the blood donor HIV prevalence fell from 3.5% in 
2011 to 1.9% in 2015, the population level prevalence of  
HIV decreased only by 0.2% from 10.6% in 2010 to 10.4% 
in 201515 which suggests that the decline in the prevalence 
of  TTIs observed in this study was not due to a general 
decrease in the prevalence of  TTIs at population level. This 
decline was probably due to improved effectiveness of  the 
blood donor education program in encouraging self-deferral 
amongst TTI positive individuals. This was also reflected in 
the prevalence for HIV of  1.9% in blood donors against the 
population prevalence of  10.4% in 2015. 
Nonetheless, the prevalence of  TTIs in Malawian voluntary 
non-remunerated blood donors (VNRBDs) was quite 
high at 1.9% for HIV, 3.6% for HBV; 1.0% for HCV and 
2.6% for syphilis when compared with other countries that 
collect blood from only VNRBDs where the prevalence is 
maintained at below 1%.17-18 
It must be stated that the prevalence for Malawian VNRBDs 
was based on unconfirmed screening test results because the 
MBTS was unable to confirm screen positives due to the 
high cost of  confirmatory testing. Unconfirmed screening 
results tend to inflate the actual prevalence as it includes some 
false positives19. It is most likely that the actual prevalence 
of  these TTIs was lower than what has been reported here. 
This therefore is one of  the methodological weaknesses of  
this study. 
The prevalence of  HIV, HBV and HCV was consistently 
lower in VNRBDs when compared with reported prevalence 
in family replacement blood donors (FRBDs). The Ministry 
of  Health quarterly HIV program reports showed an 
average prevalence of  6.3% for HIV, 5% for HBV, 1.7% for 
HCV and 2.6% for syphilis in FRBDs4-7. This is consistent 
with findings in other parts of  Africa19-20.  Allain (2010) 
argued that repeat blood donation was the main reason why 
VNRBDs are microbiologically safer than FRBDs and that 
first time VNRBDs have the same microbiological safety 
profile as FRBDs.  He argued that studies that showed the 
higher microbiological safety of  VNRBDs over FRBDs were 
confounded by age, sex and repeat blood donation and that 
there was no difference when like for like was compared20. 
The TTI prevalence among first time blood donors in this 
study indicates that FRBDs may have had similar HBV and 
lower syphilis prevalence than first time VNRBDs. However 
the HIV prevalence of  6.3% for FRBDs was 2.3 times that 
of  first time VNRBDs. As the age and sex profile of  the 
FRBDs in Malawi was not known further comparison was 
not possible and is recommended as a subject for future 
studies. 
Repeat blood donors had a significantly lower prevalence for 
each TTI than first time blood donors. 
This is because those found positive were not allowed to 
donate blood again. Nonetheless, the prevalence in this 
group was quite high at 1.2% for HIV, 2.3% for HBV, 0.9% 
for HCV and 2.1% for syphilis. This means that either the 
MBTS was allowing those who had previously tested positive 
to donate blood again or the false positive rates were high or 
the incidence of  these diseases was high in the blood donor 
population. The latter has implications on the safety of  the 
blood supply as these are candidates for donating while in 
the diagnostic window period thereby transmitting infections 
to blood recipients. It also has public health significance in 
that this newly infected population can remember events 
surrounding their infection and can provide insights into 
why and how new infections occur in an otherwise informed 
population. As such further analysis is needed to establish 
what is responsible for this high TTI prevalence in repeat 
blood donors. 
Test results for hepatitis C virus
Hepatitis C virus transmission is mainly through the parenteral 
route commonly via intravenous drug use, unsterile medical 
procedures and unsafe blood transfusions21-22. Lavanchy 
(2011), using data from an HCV prevalence study among 
Ghanaian children, extrapolated that HCV prevalence in 
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Malawi was 6.8% in 201021. The 2015 prevalence of  HCV 
in Malawian VNRBDs was lower than this at 1% for all 
blood donors and slightly higher in first time blood donors 
at 1.2% against 0.9% in repeat blood donors. This difference 
in prevalence between first time and repeat blood donors 
was statistically significant (p-value <0.001). The prevalence 
reported in this study was based on unconfirmed screening 
test results as no confirmatory tests such as Nucleic Acid 
Testing or recombinant immunoblot assay (RIBA) were 
conducted. This methodological weakness of  this study has 
already been stated earlier but is particularly significant for 
hepatitis C test results. 
Studies conducted in Malawi which confirmed positive 
screening HCV results found very high false positive rates.8, 
23 Chasela et al (2012) found 98.1% false positive results 
among HIV positive pregnant women in Lilongwe23 while 
Candotti et al (2001) found 90% false positive results among 
FRBDs in Ntcheu8. Other studies in other parts of  the world 
also found high false positive rates and correlation with low 
signal to cut off  (S/CO) ratios  of  less than 4.5.24-25 The 
HCV results in this study were based on the manufacturer’s 
recommendation of  labeling as positive all samples with an 
S/CO ratio of  ≥1. HCV has not been described as a major 
problem in Malawi suggesting that it is a disease of  low 
prevalence26. The positive predictive value of  a laboratory 
test tends to be lower when screening for infections in 
a population with low prevalence27. The low prevalence 
of  HCV, the S/CO ratio used for determining a positive 
result and the high false positive rates described by other 
researchers in Malawi and in other parts of  the world mean 
that the HCV prevalence described in this study must be 
used with caution. 
Hepatitis B virus and male blood donors
Females had about half  the HBV risk of  males [OR 0.56 
CI 0.47-0.66 adjusted OR 0.51, CI 0.43-0.60] which suggests 
that these viruses are associated with some male behavior. 
HBV transmission in endemic countries is thought to occur 
in early childhood predominantly through close personal 
contact with HBV-infected persons such as siblings or other 
children28. If  this was the main route of  transmission in 
Malawian VNRBDs, the gender differences would not be 
there. The lack of  association with age as is the case with 
HIV suggests that sexual transmission is not the main route 
of  HBV transmission in Malawian blood donors. 
We think that transmission could either be due to close shaves 
boys and men have in barbershops while girls and women go 
to salons or could be due to traditional male circumcision. 
More studies are needed to determine the factors responsible 
for this gender disparity in HBV prevalence in Malawian 
VNRBDs.
Conclusions
The mean number of  people donating blood at the MBTS 
was 39, 289 per year. The typical blood donor was a young 
unmarried male student. Hepatitis B had the highest 
prevalence in the blood donor population while hepatitis C 
had the lowest prevalence.  The prevalence of  all infections 
went down between 2011 and 2015. Repeat blood donation 
improves the microbiological safety of  the blood supply. 
There is need for focused TTI prevention strategies in these 
young TTI free blood donor populations to maintain a large 
pool of  TTI negative regular blood donors. 
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